Considerations for the Development of Chimeric Antigen Receptor (CAR) T Cell Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 31, 2024
August 10, 2024
cdb5020e-7bcf-4cca-a732-0231b04e3869
Related Documents
Considerations for the Development of Dried Plasma Products Intended for Transfusion: Guidance for Industry
Guidance DocumentDecember 19, 2019Center for Biologics Evaluation and Research
Human Gene Therapy Products Incorporating Human Genome Editing: Guidance for Industry
Guidance DocumentJanuary 29, 2024Center for Biologics Evaluation and Research
Human Gene Therapy for Hemophilia: Guidance for Industry
Guidance DocumentJanuary 28, 2020Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.